**Trader consensus on a new coronavirus pandemic in 2026 remains near-certain at 96.5% against, driven by sustained global surveillance showing SARS-CoV-2 circulation at endemic levels.** CDC and WHO data indicate test positivity around 5% or lower in monitored regions, with stable or declining emergency visits and low hospitalization rates amid widespread population immunity from prior infections and updated vaccines. Circulating Omicron lineages such as XFG produce localized upticks but lack the combination of high transmissibility, virulence, and immune escape needed for pandemic-scale impact. Authoritative monitoring networks have detected no novel coronavirus spillover with sustained human-to-human transmission or exponential growth trajectories through early October. While zoonotic risks persist and new variants could theoretically emerge before year-end, current epidemiological indicators and model consensus place such thresholds far outside observed ranges.